Business Wire

Cylance Launches Next-Generation Partner Program to Build Community of Security Experts and Partners to Deliver AI-Based Protection Solutions and Services

Del

Cylance® Inc., the company revolutionizing cybersecurity with the practical application of artificial intelligence to prevent the most advanced cyber threats, is announcing the launch of its 2017 Cylance Partner Program for channel partners.

The Cylance Partner Program offers award-winning products and a broad spectrum of services along with a wealth of support and benefits that help the company’s channel partners succeed. Cylance’s unique, patented product mix offers a cloud-based, lightweight solution that is immediately effective in protecting customers’ perimeters, even if endpoints are not connected to the Internet. This makes it easier for partners to generate high value and margin through a new range of utility-based service models, and increase their strategic security practices and offerings to their customers.

“There is a bigger problem than the volume of attacks, and it is a global issue. There are simply not enough trained personnel in IT Security to respond quickly enough to attacks, and other solutions operate on the premise that it is not only acceptable, it is inevitable that some attacks will get past security defenses. Pairing Cylance’s advanced artificial intelligence malware detection capabilities and security expertise with our channel partners’ proficiency, we are now able to offer the highest value security protection to everyone under the sun,” said Didi Dayton, Cylance’s vice president of worldwide channels. “Partners appreciate the clear operational benefit from Cylance being fully ready to protect from day one. The Cylance channel mission is go to war on inefficiency and shelf-ware, and shift the focus for customers away from reactive threat detection and poorly deployed solutions to full deployment and auto-quarantining threats across 80% of their systems within the first quarter of the investment. We want partners to be not only relevant, but absolutely critical to the success of the projects they are involved in because they can set quarantining and drastic reduction in both helpdesk tickets and machine re-images as realistic objectives. When projects are completed, and customers are protected, compliant and fully operational, then partners look good.”

Cylance takes partnering to a new level and one example of the more unique offerings includes benefits for partners whose customers are over 80 percent deployed and the opportunity for a partner to nominate a non-profit organization of their choosing to secure with Cylance, at no cost. Often, non-profits are most vulnerable to attacks due to the lack of funding and resources – an issue that Cylance hopes to address by offering its product free of charge. This unique program from Cylance, in combination with its technology offering, will help partners focus their discussions on the importance and impact that securing their endpoints can have on their organizations, employees and customers.

Gary Leibowitz, executive vice president of business development at ERASCO Group in Houston, Texas said, “The proof is in the actual deployments. Cylance is delivering on their promise to protect organizations right from the very first day. With Cylance’s use of artificial intelligence, usability suddenly becomes a non–issue, the solution gets put into place and just works without users noticing something is on their system.”

The Cylance Partner Program enables partners to offer streamlined preventive security solutions, ease-of-use, and support options that actually enable their customers’ businesses, rather than hindering them. Partners expedite the onboarding and training processes to assure that their customers can get the protection they need, from day one. The Cylance Partner Program encompasses solution providers and distributors, cloud and managed service providers, technology, system integrator, and alliance partners, as well as OEM partners. The program is tailored to each partner type and designed to reward the highest level of commitment with the highest level of benefits.

“CylancePROTECT, in my opinion, and the opinions of our sales team and technical people, and most importantly our customers, is quite a revolutionary product. It is changing the marketplace because we've had so much success,” said Audrey Lyon, general manager of sales for Aquion Pty. Ltd. in Australia.

Cylance Solution Provider partners resell Cylance products and services. Solution Provider partners include value-added resellers, national resellers, and distributors. There are four levels of Solution Provider partners: Emerald, Platinum, Gold, and National. With each of these tiers, customers will benefit from learning security best-practices, training for deploying and using Cylance’s endpoint security solution, and customized expertise in how to future-proof security for their organizations.

Hans Edin, chief marketing officer from SecureLink, said, "Teaming up with the best vendors is key to our success at SecureLink. Cylance and its amazing technology is solving difficult problems for customers today without requiring their security teams to learn difficult new tools or processes."

For more information about the benefits available to Cylance partners, or to apply to become a partner, please visit the Cylance website at www.cylance.com/partnerprogram.

About Cylance® Inc.

Cylance is the first company to apply artificial intelligence, algorithmic science and machine learning to cybersecurity to prevent the most advanced security threats in the world. Using a breakthrough predictive analysis process, CylancePROTECT® quickly and accurately identifies what is benign and what is a threat, and prevents malicious code from ever executing on a targeted system. By coupling advanced machine learning and artificial intelligence with a unique understanding of an attacker’s mentality, Cylance provides technology and services that are truly predictive and preventive against the most advanced threats. For more information visit: http://www.cylance.com/.

Cylance and CylancePROTECT are registered trademarks or trademarks owned by Cylance Inc. in the United States and other jurisdictions and may not be used without prior written permission. All other trademarks are property of their respective owners.

Social Networks
Blog: blog.cylance.com
Twitter: http://www.twitter.com/CylanceInc
LinkedIn: http://www.linkedin.com/company/cylanceinc
YouTube: www.youtube.com/cylanceinc

Contact information

Cylance Inc.
Cynthia Siemens
Director, PR and Communications
media@cylance.com
or
United States
InkHouse PR
Jill Gerig
+1(916) 215-3286
cylance@inkhouse.com
or
International
Zonic Group
Hannah Whitrow
+44 (0)1672 550126

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

ERYTECH Announces Filing of 2017 “Document de Référence” and 2017 Annual Report on Form 20-F24.4.2018 20:30Pressemelding

Regulatory News: ERYTECH Pharma (Euronext Paris: ERYP – Nasdaq: ERYP), the clinical-stage biopharmaceutical company developing innovative therapies for severe forms of cancer and orphan diseases based on its proprietary ERYCAPS platform, encapsulating therapeutic drug substances inside red blood cells, today announced that it had filed its 2017 “Document de Référence” for the year ended December 31, 2017, including the management report and the annual financial report with the “Autorité des Marchés Financiers (AMF)” and its Annual Report on Form 20-F for the year ended December 31, 2017 with the U.S. Securities and Exchange Commission (SEC). These documents can be accessed on the Investors section of the Company’s corporate website (www.erytech.com). In addition, the “Document de Référence” is also available on the AMF’s website (http://www.amf-france.org) and the Annual Report on Form 20-F is also available on the SEC’s website (www.sec.gov). Printed copies of these documents are also

Rimini Street Launches New Solutions that Further Extend the Life and Value of Enterprise Software as a Foundation for Innovation24.4.2018 16:00Pressemelding

Rimini Street, Inc . (Nasdaq: RMNI), a global provider of enterprise software products and services, and the leading third-party support provider for Oracle and SAP software products, today announced the first offerings in a family of solutions designed to provide improved competitive advantage to organizations with mature and valuable enterprise software investments that can be used as a foundation for innovation. Rimini Street’s new solutions can enable an organization to quickly and cost-effectively modernize their current enterprise software with the latest desired features and capabilities, future-proof their technical platforms against yet-unknown technology changes, and secure their systems against a constantly evolving threat environment. Rimini Street’s new solutions enable organizations to leverage their existing systems as a solid foundation for an innovative hybrid IT strategy. This press release features multimedia. View the full release here: https://www.businesswire.com/

Novaliq to Present Scientific and Clinical Research During the 2018 Association for Research in Vision and Ophthalmology Meeting in Honolulu, HI24.4.2018 15:53Pressemelding

Novaliq GmbH, a specialty pharmaceutical company with a disruptive drug delivery platform that transforms poorly soluble drugs into effective therapeutics for ophthalmology, today announced that four scientific posters will be presented at the 2018 Association for Research in Vision and Ophthalmology (ARVO) Meeting in Honolulu, HI (April 29-May 3). The variety of data to be presented reflects Novaliq’s dedication to science and clinical research. With the collection of posters, Novaliq will share clinical and pre-clinical data on its EyeSol® drug delivery technology and provide insights into the mode of action of its NOV03/NovaTears® water-free therapy for the treatment of dry eye disease (DED). Furthermore, Novaliq will present its first pre-clinical efficacy data in glaucoma. Scientific posters supported by Novaliq will include: “Influence of perfluorohexyloctane containing eye drops on tear film thickness in patients with mild to moderate dry eye disease.” Authors: Garhöfer G., Schm

Temasys Communications and Appian Partner to Power Real-Time Communications in the Contact Center24.4.2018 15:00Pressemelding

Temasys Communications announced today that Appian has integrated with the Temasys Skylink technology, enabling real-time communications, including chat and co-browsing, in Appian’s new Intelligent Contact Center (ICC) Platform. “For our contact center customers, omni-channel communications are essential. Appian is working with Temasys to provide contact centers with real-time communication channels such as chat and co-browsing via the Temasys versatile SDKs,” said Arturo Oliver, Senior Director of Product Strategy at Appian. Temasys Skylink APIs will be compatible with the Appian Intelligent Contact Center Platform, making it easy for Appian customers to add real-time communication to their applications, including chat, voice, video and co-browsing. These integrations enable users to visit a website, begin a chat session that seamlessly escalates to a voice call and extend to co-browsing — all without changing apps or establishing a new connection. “We’re thrilled to work with Appian

PPG Reports Sustainability Progress, New 2025 Goals24.4.2018 13:07Pressemelding

PPG (NYSE:PPG) today released its 2017 Corporate Sustainability Report, which details the company’s continued progress in strengthening its sustainable operations in 2017 and the launch of new, aggressive sustainability goals it aims to achieve by 2025. The report is available at sustainability.ppg.com. “PPG’s sustainability efforts go beyond product innovations to extend to our customers’ operations and the communities in which we operate,” said Mark Cancilla, PPG vice president, environment, health and safety. “We are encouraged by our progress in 2017 and excited about our new goals, which are representative of the challenges and opportunities of our current business portfolio.” The company achieved the following progress in 2017: 32 percent of sales from products that provide customers with a sustainable advantage, an increase of 60 percent since 2012. This includes the unveiling of multiple products that provide a sustainable solution, such as Sigma Air Pure, a revolutionary bio-b

Bioiberica Approves Its Combined Drug for Osteoarthritis in Five More European Countries24.4.2018 12:17Pressemelding

Bioiberica's combination of chondroitin sulphate and glucosamine hydrochloride, a slow action drug to treat osteoarthritis symptoms, was approved as an ethical drug in France, Austria, Hungary, Poland, and Finland through a mutual recognition process from Spain. ‘This approval confirms that Drug Agencies from different countries attest to the effectiveness and safety of the combination of pharmaceutical grade chondroitin sulphate and glucosamine hydrochloride. This drug has proven to reduce pain and improve mobility in people affected by knee osteoarthritis which, due to its safety profile, could also be used as an alternative by those patients with cardiovascular or gastrointestinal problems who should not be prescribed anti-inflammatory drugs chronically’, stated Dr Juan Gispert, Bioiberica's R&D director. The principle study that guarantees its effectiveness is the MOVES clinical trial, published in the Annals of the Rheumatic Diseases, which concludes that the combination of chondr